Results 81 to 90 of about 10,901 (243)
New developments in diagnostics and treatment of adult-onset focal dystonia. [PDF]
Centen LM, van Egmond ME, Tijssen MAJ.
europepmc +1 more source
Brain-Computer Interfaces for Treatment of Focal Dystonia. [PDF]
Simonyan K +10 more
europepmc +1 more source
Orofacial Drinking Tremor: A Case Series and Literature Review
Abstract Background Task‐specific orofacial tremor is a rare condition in which rhythmic oscillations of orofacial muscles occur during specific actions. Drinking tremor represents a recurrent pattern in isolated reports, although its phenomenology and underlying mechanisms remain incompletely defined.
Daniele Birreci +7 more
wiley +1 more source
Psychiatric disorders in primary focal dystonia and in Parkinson’s disease
Fernando MV Dias1, Arthur Kummer1, Flávia CP Doyle2, Estefânia Harsányi1, Francisco Cardoso2, Leonardo F Fontenelle3, Antônio Lúcio Teixeira11Neuropsychiatric Branch, 2Movement Disorders Clinic ...
Fernando MV Dias +3 more
doaj
Movement Disorders in Developmental and Epileptic Encephalopathies
Abstract Background Monogenic developmental and epileptic encephalopathies (DEE) frequently feature co‐occurring movement disorders. Gene discovery has expanded epilepsy‐dyskinesia syndromes (EDS) from classic associations such as stereotypies in Rett syndrome to PRRT2‐related infantile seizures with paroxysmal dyskinesia and crouched gait in SCN1A ...
Shekeeb Mohammad +2 more
wiley +1 more source
Focal dystonia and ataxic hemiparesis as the initial presentation of a thalamic tuberculoma: A diagnostic challenge in an immunocompetent pediatric patient. [PDF]
Sajjad F +9 more
europepmc +1 more source
Abstract Background Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT‐A). Real‐world evidence on treatment patterns remains limited. Objective This nationwide, population‐based study aimed to evaluate trends in BoNT‐A use in France between 2015 and 2023 ...
Marion Simonetta‐Moreau +3 more
wiley +1 more source
Abstract Objective Published reports on directional deep brain stimulation (DBS) have been limited to small, single‐center investigations. Therapeutic window (TW) is used to describe the range of stimulation amplitudes achieving symptom relief without side effects.
Alfons Schnitzler +24 more
wiley +1 more source
Retracted: Clinical Observation of Botulinum Toxin Injection in the Treatment of Focal Dystonia and Muscle Spasm. [PDF]
International BR.
europepmc +1 more source
Socio‐Occupational Functioning after Subthalamic Deep Brain Stimulation in Parkinson's Disease
Abstract Background Socio‐occupational functioning in patients with Parkinson's disease (PD) treated with subthalamic nucleus deep brain stimulation (STN‐DBS) is not fully captured by standard motor and quality‐of‐life scales. Objectives To characterize patient‐reported socio‐occupational functioning after STN‐DBS and explore associated clinical and ...
Gabriele Imbalzano +7 more
wiley +1 more source

